Disclaimer:
This Blog,its owner,creator & contributor is neither a research analyst nor an Investment Advisor and expressing opinion only as an Investor in Indian equities.He/She is not responsible for any loss arising out of any information,post or opinion appearing on this blog.Investors are advised to do own due diligence and/or consult financial consultant before acting on any such information.Author of this blog not providing any paid service and not sending bulk mails/SMS to anyone.

Tuesday, November 30, 2010

BS TRANSCOMM crashed from a level of Rs.220/- to Rs.146/- in continuous down circuit.I have received many queries from the readers in this regard.I feels, there is nothing wrong with the business of the company but some market operators have trapped in this counter due to the unexpected change of mood in the whole market.The pain may only continue till their shares are absorbed.Requesting to average @ CMP and hold .

Saturday, November 27, 2010

Traditionally ,Pharmaceutical companies are known as defensive bets .It also giving reasonable return in bull market ,that is why conservative investors are always giving preference for pharma companies in their portfolio. Considering the chances for low cost manufacturing and recession proof(to some extent) status of the business R&D driven pharma companies are always catching market attention. Neuland Laboratories is such a company from Hyderabad started in 1984. Neuland is promoted by Dr D R Rao and its board is supported by eminent personalities includes Mr Humayun Dhanrajgir (Former MD of Glaxo India), P V Maiya (Former chairman of ICICI Bank) Mr SP Budhiraja(Former MD of IOC) ..etc. Company is in the manufacturing of Active Pharmaceutical Ingredients(API’s) ,Contract Research and manufacturing (CRAM) and Clinical research. It also started the production of Peptides last year. Neuland having two USFDA approved manufacturing units ,one at Bonthapally and other at Pashamylaram near Hyderabad and exporting its products to more than 40 countries worldwide..It also have a strong R&D with 165 scientists. Company is one of the largest manufacturer of Ranitidine in India.Neuland’s sales in segment wise is as follows, 45% from Quinolones ,18 % Cardiovascular,16% CNS,10% Anti Ulcerants,4% Anti Asthma and rest from others. Company having two subsidiaries Neuland laboratories KK Japan and Neuland Laboratories Inc USA. Recently company started a joint venture with Cato Research Israel to offer clinical research services in India .Neuland owns 70% stake in this new company called Cato Research Neuland India Pvt.Ltd. Neuland’s R & D division has identified 13 new products for development in this year.

Financials

In the history of last 10 years ,Neuland posted a loss ( Rs.7 Cr )in last year with a sales of Rs.282 Cr.This is mainly because of the production disruption due to renovation of plants, unfavorable exchange rate and some regulatory problem of one of its products. Most of these problems are stabilized now and company is expecting better days ahead. Company has taken various cost cutting measures and steps for the optimum utilization of its resources. For the last two years ,Neuland made heavy investment in infrastructure including production facilities ,R&D and

H R. Benefits of these efforts are also expected to start from this year. It is a point to note that before the loss making last year ,in two previous years ,company posted EPS more than Rs.20/- and paid hefty dividends to share holders.Now the management is confident to achieve better results ahead and their optimism seems to be true based on the September qtr numbers. In the latest qtr Neuland posted a turnover of Rs.101 Cr v/s Rs.61 Cr and a net profit of Rs.3 Cr v/s Rs.70 lac .On an equity base of Rs.5.47 Cr ,company posted an EPS of Rs.5.30/- in latest qtr .Even after deducting the loss in first qtr ,it is expected to perform very well on a full year basis. A good management with transparency, integrity and ethics is the big positive of this Company. Currently Neuland is trading @ Rs.119/- which is even below its book value of Rs.126 /-. One may consider a BUY at current level with medium to long term view for decent return.

Thursday, November 25, 2010

NOBODY CAN BLAME A LAYMAN ,IF HE BELIEVES ,HERE IN INDIA BUSINESS CHANNELS ARE PLAYING IN THE MARKET IN A BIG WAY AND SENSATIONALIZING EVEN MINUTE NEWS TO MOVE THE MARKET IN THEIR FAVOR AFTER CREATING HUGE POSITIONS IN STOCK MARKET.INCIDENTS IN LAST FEW DAYS ARE ENOUGH TO THINK IN THIS DIRECTION.YESTERDAY IT WAS CBI AND DAY BEFORE IT WAS KOREA.NOTHING WRONG IN REPORTING ANY NEWS RELATED WITH BUSINESS AND STOCK MARKET,BUY THE WAY SUCH NEWS IS PRESENTED BY THE CHANNELS ESPECIALLY A WELL KNOWN ANCHOR WITH HIS SPECIAL BODY LANGUAGE BEFORE GETTING THE TRUE PICTURE AND SERIOUSNESS IS REALLY IDIOTIC. AFTER SENSATIONALISING SUCH STORIES IN THE AFTERNOON THEY OR THE VESTED INTEREST PARTIES RELATED WITH THEM MAY REVERSE THEIR POSITIONS AND LATER CLARIFY THAT - THERE IS NOTHING ALARMING AND INVESTORS NEED NOT WORRY ABOUT THAT .BUT BY THAT TIME POOR RETAIL INVESTORS WILL PANIC AND SUFFER HUGE LOSS DUE TO THE DECISIONS TAKEN ON THE BASIS OF EXAGGERATED STORIES.
SEBI IS TAKING A LOT OF STEPS TO CONTROL THE WRONG DOING OF STOCK MARKET INTERMEDIARIES BUT CHANNELS ARE FREE TO REPORT ANYTHING AS THEY LIKE .THEY ARE NOT SHOWING ANY SHAME TO TAKE JUST AN OPPOSITE STAND IN THE NEXT DAY ITSELF .THESE CHANNELS AND ANCHORS ARE NOT EVEN SHOWING THE STANDARD OF SOME THIRD CLASS POLITICIANS.IT IS FAIR TO IMPLEMENT AT LEAST SOME SELF MADE MINIMUM STANDARDS IN REPORTING AND BROADCASTING .THERE IS LOT OF PLAYS HAPPENING BEHIND THE CURTAIN .SO RETAIL AMATEUR INVESTORS SHOULD TAKE UTMOST CARE IN THESE VOLATILE DAYS. IT IS BETTER TO AVOID HUGE POSITIONS IN F&O SEGMENT AND AND ALSO LEVERAGED POSITION IN CASH MARKET.

Tuesday, November 23, 2010

India's largest pharma company not need any explanation for the investors. After the take over of Daiichi Sankyo ,initial hiccups on integration of management is almost over .Under the new leadership,company is expected to perform well going forward.In the latest qtr ,Ranbaxy's domestic sales posted very good performance but it partially offset by the not so good sales outside.Company is expected better performance in near future due to the beginning of the supply of Nexium API and formulations.In an effort to strengthen its local sale,company recently recruited more than 1000 field staff.All these efforts under the new management is expected to help the company to capture the past glory. Investors can add Ranbaxy in their portfolio for long term gains.Considering the volatility in the market ,it is better to buy in small lots.CMP is Rs.570/-

Sunday, November 21, 2010

Ingersoll Rand India is a subsidiary of US-headquartered Ingersoll-Rand plc . It is one of the largest manufacturers of compressed air systems in India. Its debt free status and huge reserves makes it an attractive bet for long term investors.Since there is slow growth in its overseas business,now parent company is increasing its interest in its Indian arm.Ingersoll Rand now planning to increase the capacity for manufacturing heating, ventilation and air conditioning products. Company is expected to make India as a hub for their regional requirements.For the half year ended September 2010,company posted a turnover of Rs.113 Cr (Rs.81 Cr) and a net profit of Rs.18.5 Cr (Rs.10.8 Cr) .Factors like good support from parent company, well accepted brand ,healthy balance sheet with around Rs.650 Cr cash reserves..etc , makes it an ideal candidate even for a conservative portfolio.Currently IR is trading around Rs.450/- . Investors can BUY it around Rs 430-440 for decent return in medium to long term

Friday, November 19, 2010

I have recommended a BUY on SRI ADHIKARI BROTHERS TELEVISION NETWORK on 27th February 2010 @ Rs.27/- .After touching a high of Rs.73.50/- in last week ,it is now quoting around Rs.50/- .On a standalone basis ,in the September quarter company posted a turnover of Rs.9.5 Cr v/s Rs.5.4 Cr and a net profit of Rs.1.4 Cr v/s a loss of Rs.81 lac .For the half year ended SAB posted a turnover of Rs.17 Cr and a profit of Rs.2.83 Cr and an EPS of Rs.1.61 .SAB recently launched Hindi Music Channel ' Mastiii' through its subsidiary which is a huge success.It is also expected to start few more channels in coming years.Channel business is expected to brake -even shortly.Vast experience of promoters is the main plus point of this company .Investors can BUY at current level for good return in long term

Thursday, November 18, 2010

I have recommended LUDLOW JUTE AND SPECIALITIES as a BUY on decline @ Rs.86/- ,before the declaration of second qtr result . Based on the robust performance I reiterate a BUY at current level of Rs.88/- .For the half year ended September ,Company posted a turnover of Rs.162 Cr v/s Rs.108 Cr , a net profit of Rs.16 Cr v/s Rs.4.7 Cr and an EPS of Rs.15/-

Monday, November 15, 2010

I have recommended a BUY on SRI ADHIKARI BROTHERS TELEVISION NETWORK on 27th February 2010 @ Rs.27/- .(Old Report can be Accessed HERE) .After touching a high of Rs.73.50/- in last week ,it is now quoting around Rs.59/- .On a standalone basis ,in the September quarter company posted a turnover of Rs.9.5 Cr v/s Rs.5.4 Cr and a net profit of Rs.1.4 Cr v/s a loss of Rs.81 lac .For the half year ended SAB posted a turnover of Rs.17 Cr and a profit of Rs.2.83 Cr and an EPS of Rs.1.61 .In a consolidated basis, it is expected to perform even well in coming years due to the robust performance of the newly launched Hindi Music Channel ' Mastiii' through its subsidiary.Company is also expected to start few more channels in coming years.Vast experience of promoters is the main plus point of this company .Investors can HOLD at current level and any correction below Rs.50/- due to overall negative sentiments in market(if any) may taken as a chance to ACCUMULATE it for long term

Sunday, November 14, 2010

Kilburn Chemicals is a known producerand exporter of Titanium Dioxide and Ferrous Sulphate Hepthahydrate . Its plant is located at Tuticorin and registered office is in Chennai..Titanium dioxide is widely used in the production process of Paint, Rubber, Paper, Detergents, Cosmetics, Printing Inks, Textiles, Plastics.etc. Ferrous Sulphate Hepthahydrate is mainly used in Cement industry and for manufacturing water treatment chemicals. Sulphuric acid is one of the raw material for the production ofTitanium Dioxide. Low availability and higher prices of Sulphuric acid causes for erosion of margins for the company in the past. But now,new capacities are added in various parts of the country for producing Sulphuric acid and its price and supply stabilized .Company’s user industries are also showing good growth .This situation is expected to help the company to report better numbers going forward. For the half year ended Sep , Kilburn Chemicals posted a turnover of Rs.55 Cr and a net profit of Rs.5.6 Cr . Medium to long term investors can consider it at CMP of Rs.59/-

Thursday, November 11, 2010

It is true,there may be some price manipulation immediately after the listing of BS Transcomm for giving an exit opportunity to those who bail out the public issue. Even considering this factor, I strongly feels , there is some value in it at current market price of Rs.217/- .Company has posted a turnover of Rs.342 Cr in half year and a net profit of Rs.27 Cr . On the expanded equity, it is expected to complete the FY 11 with an EPS close to Rs.25/- .It is operating in an industry with good potential and an integrated company too .Current order book position of Rs.700 + Cr giving good visibility for its business going forward. Since its IPO just completed, most of the investors are aware about the company ,so not repeating much more . I am expecting an appreciation of 50% from current level in one year time frame. CMP is Rs.217/- which is almost 15% lower than the IPO price.

Packaging companies are one of the indirect beneficiaries of the increasing consumer spending ,mainly in FMCG sector . TCPL packaging is one of the mid size packaging companies based in Mumbai .Company having four plants – three in Silvassa and one in Haridwar.It is one of largest manufacturers of printed folding cartons in India . Its products list include Printed blanks & outers, Folding cartons, Litho Lamination, Plastic cartons, Blister paper … etc .Company also exporting its products to countries like UK,USA, UAE. Many of the Indian FMCG majors are the customers of the company like ITC, Radico Khaitan, Jagatjit Industries Ltd., Khoday's, Nestle, Glaxo Smithkline, Kellogg India, Heinz, Amul, Hindustan Unilever Ltd , Colgate, Godrej Sara Lee, Godrej Consumer Products, Cavin Kare, Marico, Himalayan Drugs ..etc . Even if this company is not so popular among investors ,it is one of the best play in listed packaging space . TCPL is growing steadily and paying dividend without any interruption for the past many years . Last full year ,company posted a turnover of Rs.188 Cr .PBDT is Rs.20 Cr and CEPS is Rs.21/- .For the current year ,company is expected to improve its financials mainly due to better demand situation and benefits from recent capacity addition. At CMP of Rs.55 /- ,it is a good BUY for medium to long term.

Tuesday, November 9, 2010

After a long period ,textiles companies are making big profits due to good demand and better realization. Improvement in their bottom line will surely translate into more expansion and modernization programmes . This will surely improve the prospects of textile machinery makers going forward. Veejay Lakshmi Engineering Works Ltd (VLEWL) is a Coimbatore based textile machinery manufacturer started operations in 1974.Its products list includes Two-For-One twisters, Automatic cone Winders ,Precision Propeller winders, Random Assembly Winder ..etc For the past many years ,company’s performance was badly affected due sluggish demand which is now reviving . Any decision to continue the presently suspended TUFS will be an added advantage for textile machinery sector as a whole. For the half year ended September 2010 , company posted a turnover of Rs.50 Cr (Rs.29 Cr) and a net profit of Rs.2 Cr (Loss of Rs.1 Cr) and an EPS of Rs.4.13 /- . Medium to long term investors may consider a BUY at CMP of Rs.76/-

Monday, November 8, 2010

Hearty welcome to you all. On behalf of the Board of Directors of Kaveri Seed Company Limited and on my own behalf it is my privilege and honour to extend a very warm welcome to the 23rd Annual General Meeting. At the outset, I am thankful to all the shareholders of the Company for their whole hearted support and cooperation in furthering the overall growth and progress of the Company.

I am sure, you all must have gone through the Annual Report of the Company for the year 2009-10. Your Company’s performance for the year under review has been quite satisfactory despite aberrant weather- failure of monsoon leading to drought followed by devastating floods, factors that destabilize agriculture. It is heartening to note your Company’s business has significantly improved on operational performance compared to yesteryear and records a positive financial growth. The year’s Gross Turnover of Rs. 165.00 Crores enhanced a growth rate of 32% where as the profit after tax Rs.29.07 Crores improved the growth rate of 16.77%. The accomplished financial growth sustains the Company’s business and help attaining market leadership in seed and agribusiness. Your Company will Endeavour to show remunerative pathways to shareholders as well as taking care of well being of farmers. Investors in Kaveri Seed Company Limited can confidently look forward for robust and sustainable growth in the years ahead.

The Indian Seed Industry is vibrant and grown over the years to become the fifth largest in the world with an estimated value of 1500 million US $ and an annual growth rate of 12% to 13 %. India is one among the few countries in the world where the seed sector is well positioned with the potential to become global seed production hub, if nurtured carefully. With the food crisis looming large world over, it is evident that the future rests with countries wielding grain power and those in agri business realize quality seed is the key to such empowerment.

Investment in Agriculture R&D is the most effective way of ensuring food security and economic growth. The pressing need is for quality seed of varieties and hybrids that are not only high yielding but resilient to less input- water, fertilizers etc. Thus food security is interwoven with the seed security. The Kaveri Seed Company’s R&D targeted its research for developing hybrids that excel in the market with quality assurance. Your Company with vast experience in seed production of major agricultural crops backed by a very strong in-house R&D program for crops-maize, cotton, sunflower, bajra, sorghum, rice and several vegetable crops nurtured a competitive edge in seed and agribusiness. With over 600 acres of farm land owned by the Company and dedicated team of researchers, the Company is conscious of the changing needs of farmers and consumers to design and develop productive hybrids that fetch rewarding returns. Being India’s leading National Seed Company, the R&D focus centers round combined use of conventional breeding and biotechnology to advance the yield frontier and stabilize it through incorporation of genetic resistance to biotic and abiotic stresses. During the year under report, our R&D strived hard to accelerate to new and sustained levels of innovation as exemplified by the performance of pipe line hybrids in All India Coordinated Trials and commercial launching of premier hybrids.

Vegetable consumption, nationwide is increasing along with seed volume and value. In view of demand for higher quality and more variety in vegetables, Kaveri R&D is laying new thrust to vegetables with emphasis on tomato, okra and chilly. All of us anticipated approval for BT brinjal in India that is not to be. Regardless of this development, commercialization of GM vegetables, particularly in developing countries like ours, is inevitable. Despite current public opposition to GM technology, environmental, quality and production efficiency benefits will eventually favour wide adoption of the technology in the country. Once the way is paved for Bt Brinjal, GM rice, maize, wheat and a number of vegetable crops follow the suit, heralding an era of biotech crops. As biotechnology steers the breeding process in the near future, our R&D is being geared up by strengthening human resources and expanding the infrastructure. A battery of transgenic containment units are getting ready at Gowraram and plans are afoot to build mega greenhouses for Flori and Olericulture. Fortifying Bt cotton with herbicide tolerance (HT) and drought tolerance (DT) is our research agenda. After Bt cotton it is the turn of hybrid rice with huge market potential. Whatever may be the current seed production problems, they are not insurmountable. And we need to overcome to sustain the technological option for increasing food production.

On the product front, the Company is successful in launching two of its premier Bt cotton hybrids in the brand names of Jadoo and Jack pot and a pearl millet hybrid, Super Boss. Sampada (red gram) Sampoorna (paddy) are the newly launched varieties. Based on the performance at National level, two of our maize hybrids, Kaveri 50 and KMH 25K60 along with bajra hybrid, MH 1553 were identified by Varietal Identification Committee for eventual notification.

Germplasm is the genetic wealth of the Company. The vast collection of germplasm that accrued over the year has been streamlined for conserving in “Gene Bank” In order to establish legal ownership of the Company’s hybrids and their parental lines, efforts are underway to registering the lines with PPV & FR authority. Till date, ~ 100 applications were filed with PPV & FRA.

To augment natural resources-land and water, the Company has embarked on plans to bring more area under plough and judicious use of scarce water. Towards this goal, farm area to the tune of nearly 120 acres has been brought under cultivation of crops for commercial production of seed. The rain water harvest is in place for use in new cropped area. In addition, drip irrigation has been extended to cover more area in Gundla Narasingpur farm and elsewhere.

Your Company is fully dedicated to improve the field and vegetable crops continuously. Besides corn and sunflower, cotton, pearl millet, rice, grain sorghum, mustard and various hybrid vegetables are part of our extensive product portfolio in which the company enjoys a sizeable share in the Indian seed market. Our vegetable crops include tomato, okra, hot pepper, water melon, bitter gourd and coriander. The Company had made its presence in the market by releasing high yielding hybrids of these vegetable crops. In addition, to these products the Company has extended its business of Micronutrients and Bio-products to produce chemical –free and eco-friendly pesticides, fungicides and yield enhancers and thereby augmenting the product assortment.

Your Company is on the ascending path to reach new heights in seed and Agri- Business. Your Company has recognized One among the Top 39 Indian Companies in the world leading business magazine of “Forbes Asia” published under a list of 200 top-performing small and midsize Companies in “Asia’s Best Under A Billion”.

I express my sincere gratitude to our shareholders, farmers, dealers, bankers, employees, the Central and State Governments and other regulatory authorities/agencies for providing continuous support at all times and look forward to have the same in our future endeavors. I wish to express my sincere appreciation to my colleagues on the Board for their continued support. I am grateful to you all for your cooperation and the trust that you have reposed in us.

Saturday, November 6, 2010

This company was originally promoted by Mr C N Balu in 1986 and started operations in Karnool Dt of Andhra Pradesh.In the earlier stages,company’s business was limited only in the processing of edible oil ,mainly sunflower. Company had a marketing alliance with ITC and its products were sold mainly in the brand name of ‘Sundrop’ .Later ITC took equity participation in this company and its name changed to ITC Agro. In 1997 ConAgra took major stake in this company . But even after this stake sale ITC hold about 30% stake in this company. Even with a majority stake ,ConAgra was not aggressive and not interested to bring any of its popular international offerings to Indian market through this company. This may be because of two reasons .First one is the presence of ITC in its management itself .Even if ITC held some interest in this company , during this period they were trying to enhance their presence in Indian food market through the parent company itself. In one sense ,ITC itself is a potential competitor for Conagra .Sensing this ,Conagra seems to be reluctant to introduce more products from their international brands through a company shared with the future competitor. Secondly .Indian market was not prepared to accept RTS /snack food type offerings at that time ,which also limited its scope here. But now India has grown a lot and the habits of Indians changing very positively for accepting the products of a company like ConAgra . What is positive at this juncture is the decision of ITC to completely exit from this company . Now ITC is selling their stake through market operations and some mutual funds are accumulating this stock. Big investors like Rakesh Jhunjunwala already entered in this scrip in the past . Currently ITC’s holding in this company is very limited and it is expected to exit completely in this quarter itself. At present Agrotech foods offering only limited products which includes Sundrop edible oil, ACT II Popcorn , Sundrop Peanut Butter, Healthy World Quick Dried Tender Green Peas, Crystal sunflower oil ..etc. Now the circumstances are very favorable for aggressive launch of its well accepted products in vast Indian market , and it is every reason to believe ConAgra can’t ignore this market for long time . Supported by a world leader, Agro tech foods may turn as a multibagger even from current alltime high level .The moot question is the attitude of Con Agra towards this company going forward .Risk takers with patience may go for it at CMP Rs.327/-

Thursday, November 4, 2010

WISHING ALL MY READERS , A VERY HAPPY DIWALI AND A PROSPEROUS YEAR AHEAD

Presenting 5 stock ideas for this Diwali.First 3 for all and the rest only for high risk takers.

* based on the closing price of .3/11/2010

1) YES BANK CMP 372.50/-

YES BANK, the new generation, fastest Growing Private Bank in India, is an outcome of the professional entrepreneurship of its Founder, Rana Kapoor who has a brand in the Indian banking industry. The bank providing all banking services such as Corporate and Institutional Banking, Financial Markets, Investment Banking, Corporate Finance, Treasury operations, Branch Banking, Business and Transaction Banking and Wealth Management business to corporate and retail customers. Yes Bank presents a remarkable record in every operational metrics since its inception like Consistent improvements, year on year in top- line as well as bottom-line growth, industry-best figures on RoE and cost-efficiency with the lowest NPAs.

The bank’s 69.8 per cent business contributes corporate and institutional banking, followed by commercial banking at 19.6 and branch banking at 10.6 per cent, respectively. For the second qtr ended Sep 2010, Yes Bank reported robust net profit growth of 57.8% yoy and 12.7% qoq to Rs. 176cr, well above street estimates. The Bank’s Advances grew by a strong 15.6% qoq and 86.3% yoy compared to a marginal industry qoq growth of 0.6%. Deposits increased 32.3% qoq and 106.6% yoy compared to 1.6% qoq industry growth. NII registered a 95.8% yoy growth. During the quarter, the bank’s gross NPA ratio stood at 0.2% and net NPA ratio at 0.1%. The bank’s capital adequacy ratio improved to 19.4%, with tier-I capital of 11.0% .

Presently, the bank has 171 branch networks across the country and it has received 91 new branch licenses. The bank plans to have a network of 250 branches by June 2011 and 400 by FY 2012. The bank successfully raised over Rs 1,170 crore through upper (Rs 640 crore) and lower tier II (Rs 306 crore), and tier I perpetual bonds (Rs 225 crore) in Q2. It is expected a CAGR of 51 % in advances and 56 % in deposits for FY 2010 to 2013.

At the CMP around Rs. 370, the stock is trading at 20.5Xs its TTM EPS of Rs. 18 and 3.9Xs average book value. It is expected to report an EPS of Rs.30/- by FY 2012 .Considering the Bank’s high growth, Stable asset quality, professional management, moreover the India’s growth story; l YESBANK should register new records in its financial front as well as in market going forward.

Selan Exploration is a Gujarat based Oil exploration and Production Company having rights to develop three proven oil fields in Gujarat – Bakrol,Lohar and Indora.As per estimates the Bakrol oil field having a reserve of 73 million barrels and Indora having much more . If we take the entire reserves as 100 million barrels on an extremely conservative basis and the average oil price as $ 75 /barrel , the value of reserve will be around Rs.30000 Cr. Selan is one of the low cost producer and even after providing the share of government and deducting the production cost, company is sitting on a gold mine. At a time of comparatively lower oil prices ,as a prudent strategy ,company now concentrating in more Seismic data acquisition , Processing and interpretation activities rather than drilling new wells .Result of this can be utilized at a time of better oil prices lately .Company also awarded two more fields namely Ognaj and Karjisan. Since the Oil prices are moving in a narrow range ,oil producing companies are not in limelight for the time being. But it is expected to move to higher level in correlation with the world wide recovery . So it is a perfect fit for true investors with patience for reaping big gains in future. CMP is Rs.355/-

Aries Agro Limited offers the widest range of products in the micro-nutrient sector . The company also producing value added secondary nutrients and water soluble NPK complex fertilizers. Aries recently expanded its product line to cover bio degradable chelates, organic chelates, sea weed extracts, seeds, synthetic chemical pesticides, bio fertilizers, bio pesticides and farm equipments. During FY 10 the company launched 15 new products, taking its total products tally to 76 brands. Over past many years, Aries has built an extensive distribution network across 24 states, through a network of around 5000 distributors in the country. In addition, it also actively began marketing to institutions and also scaled up its sales under State development and drought/flood relief schemes. Currently, Aries products being sold in 1,75,000 villages located in 375 districts of the country. Aries have one of the largest manufacturing bases of specialty plant nutrition solutions in India. It has also expanded manufacturing base in overseas. As of the end of 2009-10, Aries has a total manufacturing capacity of 84,600 MT per annum spread across 6 factories in India and an additional 70,000 MT per annum at its 2 Units in Fujairah and Sharjah. This is the largest world class manufacturing base of specialty plant nutrition solutions set up by any Indian Company.

In the current fiscal year the company plans to launch an additional 6 products. This will include further specialty plant nutrients, farm equipment and plant protection products, adding on to its already extensive range of 76 brands. The GoI’s favorable policies to improve food production using scientific methods and most modern techniques opens immense growth potential for the fertilizers and the micronutrients business in the country and Aries being one of the largest and the most established player in micronutrients space is expected to benefit from the same. CMP is Rs.163/

HIGH RISK BUYS

If you are not interested to take very high risk , just ignore the below mentioned two companies

4) KREBS BIOCHEMICALS CMP Rs.37.95/-

Krebs Biochemicals was a darling of investors in the first half of 2000 and touched a high of Rs.276 /- in 2004. This is the only listed pharma company with equity investment of two pharma majors , Ranbaxy laboratories and Dr.Reddy’s lab .Interest of both these biggies itself is a testimony for the potential of Krebs. This is one of the very few pure listed Active Pharma Ingredient(API) makers using the fermentation technology. The only another pure listed player is Biocon. This Hyderabad based company is promoted by Mr.RT Ravi who has over 34 Years of experience in Applied Biochemical Research. Krebs had two units ,one in Nellore and other in Vizag .The unit 1 was dedicated for the production of Ephedrine and Psuedophedrine and unit 2 for Statins like Lovastatin and Simvastatin. The complexity of fermentation technology is a real entry barrier into this industry .

In 2004, Krebs posted a turnover of Rs.101 Cr ,net profit of Rs.13.5 Cr and an EPS of Rs.23/- Its misfortune started in the form of the arrest of some people related with a narcotic racket overseas. One of the products of the company ‘Pseudoephedrine’ is used in medicines for cough and cold .On the other hand it can also be used to produce ‘Methamphetamine’ – a narcotic drug. After the above mentioned arrest ,the authorities tracks the source of Pseudoephedrine which end with Krebs biochemicals. Even the company repeatedly affirm that they are selling the product only to the bulk buyers overseas and not aware about the end users, the drug authorities cancelled the license for manufacturing ‘Pseudoephedrine’.This incident badly affect the entire operations of the company and it moves to red. Its diversification to some unrelated fields also adds fuel to the fire.

Current Situation

Company is Shy to share information with any outsider ,so no chances to get direct information from the management about the new developments.. So I am forced to make conclusions based on the available information’s in the public domain and certain assumption.Currently ,the day to day operations are managed by Mr Avinash Ravi son of the main promoter R T Ravi. Avinash is a Bio process Engineer from the university of New Southwales,Australia. He has done his project work in Fermentation and Laboratory Control from Suntroy Brewary, Queens Land, Australia and done his student Exchange Programme from University of Alberta .Canada. He is specially qualified in Production and purification of Biotechnology products Monoclonal Anti Bodies, R-DNA Products..etc. Now,company stopped its all non core activities and concentrating only in pharma business. For the past may years company posted losses and the reason as per the latest annual report is the non operational status of its plant 1 located at Nellore. Company also expressed its optimism to find out some arrangements with big pharma companies to re start the production of Unit 1 . What catch our attention is the performance in the second quarter of current FY .In September qtr company doubled its turnover from Rs.10 Cr to Rs.21 Cr and reduced the loss from Rs.6 Cr to Rs.1.8 Cr . It is a fact that the skills of the promoters and infrastructure of the company is a big asset and it is not easy to replicate in an industry like Fermentation and Biotechnology . As I have mentioned in the beginning ,interest of two pharma majors is not a co-incident in this high entry barrier industry.If the latest financial performance is any indication ,some surprise may happen in this company by next Diwali. Don’t forget, all of these are depends on lot of IF’s and let us hope the old good days will come back in future for Krebs .

Tuesday, November 2, 2010

Technofab Engineering is a 40 years old New Delhi Based EPC player. In its earlier stage ,it was only handling fabricating and later diversified into EPC business. It also have presence in Balance-of-Plant (BoP) and doing electro-mechanical projects on a complete turnkey basis. Company have reasonable experience in Nuclear power ,Water and waste water segment. Company already successfully executed more than 130 projects for various clients includes BHEL ,NTPC …etc. Technofab also operating in countries like Fiji,Kenya ,Ethiopia ..etc where growth momentum is expected in future. Construction of various new power projects are expected to bring big business to companies like Technofab. Recently company extended its business into other related sectors like Process Control Instruments, Thermal Mass Flowmeter, Mass Flowswitch,valves and control devices by its investment in Woodland Instruments . Company completed last year with a turnover of Rs 200 Cr and a net profit of Rs.19 Cr. Company’s current order book is above Rs.700 Cr which gives good visibility for earnings going forward. For the three months ended September quarter Technofab posted a turnover of Rs.73 Cr ( Rs.43 Cr) and a net profit of Rs.6.5 Cr (Rs 3.9 Cr). Medium to long term investors can consider a Buy at CMP of Rs.222/-

Monday, November 1, 2010

Amrit Banaspati is a 40 year old vegetable oil company based in Rajpura ,Punjab.

Company is selling edible oil from Groundnut, Cottonseed, Rice Bran, Soyabean, Mustard, and Sunflower . Company’s different products are marketed under the brands ‘GINNI’ ,‘GAGAN’and ‘ MERRIGOLD’ .Company is mainly operating with three products categories, viz – Lifestyle Products, Premium Products and Consumer Products. Under the lifestyle products category ,company selling GINNI NUTRI DELIGHT NUGGETS, MERRIGOLD TABLE MARGARINE and MERRILITE vegetable fat. Under the premium products category ,it is offering GINNI GOLD REFINED SUNFLOWER OIL, REFINED GROUNDNUT OIL, REFINED COTTONSEED OIL and REFINED RICEBRAN OIL . Its offering under Consumer products category includes GAGAN VANASPATI, GAGAN GOLD VANASPATI , GINNI PLUS REFINED OIL , GINNI REFINED PALM OIL , and GINNI REFINED SOYABEAN OIL. Company having a good dealer network of 1400 dealers in 850 cities across India .Its products are well established and having good brand loyalty . Since major part of its raw material ( Crude Palm Oil) is imported from foreign countries, considering the current exchange rate scenario, company is in a good position . Company posted a turnover of Rs.235 Cr in latest qtr with a net profit of Rs.4 Cr . It is expected to close the full year with an EPS close to Rs.18/- .One may consider buying in small lot at CMP of Rs.114/-